Table 2 The cutoff points and outcome for 23 immunomakers and 7 clinicopathological variables in predicting postoperative distant organ metastasis in the training cohort (n=319)
95% CI | ||||
|---|---|---|---|---|
Variables | RR | Upper | Lower | P- value |
Gender (male vs female) | 2.484 | 1.397 | 4.415 | <0.001 |
Age (⩽60 vs >60 years) | 0.774 | 0.551 | 1.087 | 0.143 |
Tumour location (upper and middle vs lower third) | 0.814 | 0.579 | 1.144 | 0.256 |
Cell differentiation (G1–2 vs G3) | 0.457 | 0.332 | 0.630 | <0.001 |
Tumour length (⩽2.5 vs >2.5 cm) | 0.428 | 0.220 | 0.832 | 0.005 |
pT categories (T1–2 vs T3–4) | 0.477 | 0.321 | 0.707 | <0.001 |
pN categories (N0 vs N1–3) | 0.333 | 0.239 | 0.465 | <0.001 |
Angiogenesis ( n) | ||||
b-FGF (⩽2.33 (264) vs >2.33 (55)) | 1.190 | 0.731 | 1.939 | 0.473 |
Cox-2 (⩽1.33 (253) vs >1.33 (66)) | 0.557 | 0.397 | 0.781 | 0.001 |
VEGF (⩽1.33 (69) vs >1.33 (250)) | 0.530 | 0.308 | 0.914 | 0.013 |
Apoptosis ( n) | ||||
Bcl-2 (⩽5 (270) vs >5 (49)) | 0.716 | 0.480 | 1.070 | 0.120 |
NF-κB (⩽5 (174) vs >5 (145)) | 0.302 | 0.202 | 0.451 | <0.001 |
Survivin (⩽9.33 (278) vs >9.33 (41)) | 0.919 | 0.566 | 1.493 | 0.736 |
Cell adhesion molecules ( n) | ||||
CD44ν6 (⩽10 (201) vs >10 (118)) | 0.759 | 0.541 | 1.064 | 0.113 |
E-cadherin (⩽2.67 (142) vs >2.67 (177)) | 1.301 | 0.927 | 1.825 | 0.128 |
Integrin β1 (0 (238) vs >0 (81)) | 2.121 | 1.250 | 3.597 | 0.002 |
Cell cycle regulators ( n) | ||||
Cyclin B1 (⩽6 (281) vs >6 (38)) | 4.102 | 1.367 | 12.312 | 0.002 |
Cyclin D1 (⩽3.33 (183) vs >3.33 (186)) | 0.600 | 0.427 | 0.844 | 0.003 |
Ki67 (⩽7 (256) vs >7 (63)) | 0.580 | 0.411 | 0.820 | 0.004 |
p21Waf1/Cip1 (⩽8.67 (183) vs >8.67 (136)) | 0.332 | 0.227 | 0.484 | <0.001 |
DNA repair ( n) | ||||
ERCC1 (0 (255) vs >0 (64)) | 1.322 | 0.819 | 2.134 | 0.237 |
EGFR ( n) | ||||
EGFR (⩽6 (119) vs >6 (200)) | 2.370 | 1.684 | 3.336 | <0.001 |
HER2/neu (⩽6 (231) vs >6 (88)) | 0.415 | 0.301 | 0.572 | <0.001 |
MMP and inhibitors ( n) | ||||
MMP-1 (⩽3 (190) vs >3 (129)) | 1.380 | 0.956 | 1.992 | 0.079 |
MMP-11 (⩽3.33 (145) vs >3.33 (174)) | 1.252 | 0.892 | 1.758 | 0.193 |
TIMP-2 (⩽8 (294) vs >8 (25)) | 2.579 | 0.880 | 7.559 | 0.046 |
uPAR (⩽2.33 (200) vs >2.33 (119)) | 1.735 | 1.158 | 2.600 | 0.005 |
Tumour suppressor genes ( n) | ||||
NM23-H1 (0 (287) vs >0 (32)) | 2.509 | 0.987 | 6.374 | 0.026 |
P53 (⩽10.33 (167) vs >10.33 (152)) | 1.177 | 0.835 | 1.659 | 0.351 |
Rb (⩽0 (299) vs >0 (20)) | 0.562 | 0.350 | 0.903 | 0.037 |